The Impact of Comorbid Nasal Polyps on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study

被引：0
|
作者：
Liu, M. C. [1 ,2 ]
Bagnasco, D. [3 ]
Matucci, A. [4 ]
Pilette, C. [5 ,6 ]
Price, R. G. [7 ]
Maxwell, A. C. [8 ]
Cristancho, R. Alfonso [9 ]
Jakes, R. W. [10 ]
Yang, S. [9 ]
Howarth, P. [11 ]
Cheema, A. S. [12 ]
机构：
[1] Johns Hopkins Asthma & Allergy Ctr, Div Clin Immunol & Allergy, Baltimore, MD USA
[2] Johns Hopkins Asthma & Allergy Ctr, Div Pulm & Crit Care Med, Baltimore, MD USA
[3] Univ Genoa, Osped Policlin San Martino, DIMI Dept Internal Med, Allergy & Resp Dis, Genoa, Italy
[4] Univ Florence, Azienda Osped Univ Careggi, Immunoallergol Unit, Florence, Italy
[5] UCLouvain, Clin Univ St Luc, Dept Pulm Med, Brussels, Belgium
[6] UCLouvain, Inst Expt & Clin Res, Brussels, Belgium
[7] GSK, Biostat, Stevenage, Herts, England
[8] GSK, Real World Study Delivery, Value Evidence & Outcomes, Global Med, Stevenage, Herts, England
[9] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[10] GSK, Epidemiol, London, England
[11] GSK, Specialty Care TA, Global Med, Brentford, England
[12] Alpha Med Res, Mississauga, ON, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4837
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The impact of mepolizumab self-administration on real-world outcomes in patients with severe asthma: Post hoc analysis of REALITI-A at 2 years
    Canonica, G. W.
    Demetriou, L.
    Schleich, F.
    Pelaia, G.
    Bernstein, D.
    Lee, F. E. H.
    Price, R. G.
    Howarth, P.
    ALLERGY, 2023, 78 : 185 - 186
  • [22] Mepolizumab Provides Real-World Clinical Benefits in Severe Eosinophilic Asthma Irrespective of Baseline Lung Function: Results From the REALITI-A Study at 2 Years
    Bagnasco, D.
    Pilette, C.
    Lougheed, M.
    Caruso, C.
    Echave-Sustaeta, J.
    Dennison, P.
    Verghis, R.
    Jakes, R.
    Rais, M.
    Howarth, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [23] Influence of Baseline Total IgE and History of Previous Omalizumab Use on the Impact of Mepolizumab in Reducing Rate of Severe Asthma Exacerbations: Results From the Real-World REALITI-A Study
    Lee, Jason
    Pollard, Stephen
    Liu, Mark
    Schleich, Florence
    Pelaia, Girolamo
    Almonacid, Carlos
    Heaney, Liam
    Chaudhuri, Rekha
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Price, Robert
    Maxwell, Aoife
    Howarth, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB191 - AB191
  • [24] REAL-WORLD BENRALIZUMAB EFFECTIVENESS AMONG ASTHMA PATIENTS WITH COMORBID NASAL POLYPS: RESULTS FROM THE ZEPHYR2 STUDY
    Carstens, D.
    Genofre, E.
    Emmanuel, B.
    Mu, F.
    Yang, D.
    Cook, E.
    Betts, K.
    Chung, Y.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S37 - S37
  • [25] Mepolizumab improves lung function under real-world settings in REALITI-A study
    Schleich, Florence
    Chaudhuri, Rekha
    Canonica, Giorgio Walter
    Munoz Gall, Xavier
    Funke, Faustina
    Pek, Bonavuth
    Pollard, Stephen
    Maxwell, Aoife
    Joksaite, Sandra
    Price, Robert G.
    O'Reilly, Ronan
    Van Dyke, Melissa K.
    Yang, Shibing
    Howarth, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [26] THE SUSTAINED OCS-SPARING EFFECT OF MEPOLIZUMAB: RESULTS FROM THE REAL-WORLD REALITI-A STUDY AT 2 YEARS
    Pollard, S.
    Offenberger, J.
    Lee, F.
    Liu, M.
    Alfonso-Cristancho, R.
    Price, R.
    Howarth, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S43 - S43
  • [27] REDES Study: Mepolizumab Is Effective in Patients With Severe Asthma and Comorbid Nasal Polyps
    Arismendi, E.
    Cisneros, C.
    Blanco-Aparicio, M.
    Martinez-Moragon, E.
    Quirce, S.
    Conejero, D. Banas
    Lopez-Moure, A.
    Sanchez-Herrero, M. G.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2023, 33 (06) : 476 - 479
  • [28] Real-world effectiveness of mepolizumab in patients with severe asthma with/without chronic rhinosinusitis with nasal polyps: pooled analysis from European cohorts
    Palomares, Ines
    Loukides, Stelios
    Schleich, Florence
    Chaudhuri, Rekha
    Leuppi, Joerg
    Heffler, Enrico
    Domingo, Cristian
    Micheletto, Claudio
    Paulsson, Thomas
    Gaw, Nina
    Kallinikou, Nadia
    Mcdermott, Eleanor
    Vossen, Carla
    Guelfucci, Florent
    Menon, Jyothi
    Ngami, Armel
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [29] Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Mepolizumab in Real-Life Settings: The Prospective, REALITI-A Study
    Chaudhuri, R.
    Canonica, G. W.
    Bals, R.
    Lougheed, M. D.
    Pilette, C.
    Ramos-Barbon, D.
    Pollard, S.
    Maxwell, A.
    Worsley, S.
    Van Dyke, M. K.
    Joksaite, S.
    Howarth, P.
    Cristancho, R. Alfonso
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [30] Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis
    Liu, Mark C.
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert G.
    Maxwell, Aoife C.
    Alfonso-Cristancho, Rafael
    Jakes, Rupert W.
    Lee, Jason K.
    Howarth, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (12): : 3650 - +
12345